News

Crossject: validation of the ZENEO® Midazolam clinical batch

« Cenexi: the ideal partner for sterile filling »

Cenexi will be at CPhI Worldwide from November 9th to 11th 2021

OSE Immunotherapeutics announces an agreement with Cenexi

Cenexi and Crossject strengthen their partnership

Christophe DURAND, new CEO at Cenexi